243 related articles for article (PubMed ID: 28181122)
1. Association between rheumatic diseases and cancer: results from a clinical practice cohort study.
Bellan M; Boggio E; Sola D; Gibbin A; Gualerzi A; Favretto S; Guaschino G; Bonometti R; Pedrazzoli R; Pirisi M; Sainaghi PP
Intern Emerg Med; 2017 Aug; 12(5):621-627. PubMed ID: 28181122
[TBL] [Abstract][Full Text] [Related]
2. Rheumatic syndromes: clues to occult neoplasia.
Naschitz JE; Rosner I; Rozenbaum M; Zuckerman E; Yeshurun D
Semin Arthritis Rheum; 1999 Aug; 29(1):43-55. PubMed ID: 10468414
[TBL] [Abstract][Full Text] [Related]
3. [A review of paraneoplastic rheumatic syndromes].
Dabrowska-Zimoń A; Brzosko M
Ann Acad Med Stetin; 2006; 52 Suppl 2():17-22. PubMed ID: 17474176
[TBL] [Abstract][Full Text] [Related]
4. Neoplastic associations of rheumatic diseases and rheumatic manifestations of cancer.
Benedek TG
Clin Geriatr Med; 1988 May; 4(2):333-55. PubMed ID: 3288324
[TBL] [Abstract][Full Text] [Related]
5. Musculoskeletal syndromes associated with malignancy (excluding hypertrophic osteoarthropathy).
Naschitz JE; Rosner I
Curr Opin Rheumatol; 2008 Jan; 20(1):100-5. PubMed ID: 18281865
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated neuromusculoskeletal syndromes. Recognizing the rheumatic-neoplastic connection.
Marmur R; Kagen L
Postgrad Med; 2002 Apr; 111(4):95-8, 101-2. PubMed ID: 11985137
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of systemic sclerosis, scleroderma-like syndromes and neoplastic diseases.
Ciołkiewicz M; Domysławska I; Ciołkiewicz A; Klimiuk PA; Kuryliszyn-Moskal A
Pol Arch Med Wewn; 2008 Mar; 118(3):119-26. PubMed ID: 18476458
[TBL] [Abstract][Full Text] [Related]
8. [Rheumatic manifestations and neoplasms].
Jesus G; Barcelos A; Neves C; Crespo J
Acta Reumatol Port; 2006; 31(4):305-21. PubMed ID: 17334043
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated rheumatic disorders: clues to occult neoplasia.
Nashitz JE; Rosner I; Rozenbaum M; Elias N; Yeshurun D
Semin Arthritis Rheum; 1995 Feb; 24(4):231-41. PubMed ID: 7740303
[TBL] [Abstract][Full Text] [Related]
10. Rheumatic diseases and malignancy--is there an association?
Leandro MJ; Isenberg DA
Scand J Rheumatol; 2001; 30(4):185-8. PubMed ID: 11578009
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes.
Solans-Laqué R; Pérez-Bocanegra C; Salud-Salvia A; Fonollosa-Plá V; Rodrigo MJ; Armadans L; Simeón-Aznar CP; Vilardell-Tarres M
Lupus; 2004; 13(3):159-64. PubMed ID: 15119543
[TBL] [Abstract][Full Text] [Related]
12. Rheumatic diseases and cancer.
Cash JM; Klippel JH
Clin Exp Rheumatol; 1991; 9(2):109-12. PubMed ID: 2060156
[No Abstract] [Full Text] [Related]
13. [Paraneoplastic rheumatic syndromes].
Pileckyte M; Baliūnaite R; Tamulaitiene V
Medicina (Kaunas); 2003; 39(5):443-7. PubMed ID: 12794365
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic rheumatologic syndromes.
Azar L; Khasnis A
Curr Opin Rheumatol; 2013 Jan; 25(1):44-9. PubMed ID: 23026875
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of paraneoplastic rheumatic syndromes and their antibody profile among patients with solid tumours.
Rugienė R; Dadonienė J; Aleknavičius E; Tikuišis R; Distler J; Schett G; Venalis P; Venalis A
Clin Rheumatol; 2011 Mar; 30(3):373-80. PubMed ID: 21225302
[TBL] [Abstract][Full Text] [Related]
16. [Rheumatoid symptoms in patients with hematologic neoplasms].
Kleinert S; La Rosée P; Krüger K
Z Rheumatol; 2017 Oct; 76(Suppl 2):38-45. PubMed ID: 29330756
[TBL] [Abstract][Full Text] [Related]
17. Rheumatic manifestations of cancer.
Ashouri JF; Daikh DI
Rheum Dis Clin North Am; 2011 Nov; 37(4):489-505. PubMed ID: 22075194
[TBL] [Abstract][Full Text] [Related]
18. More on polymyalgia rheumatica (PMR) as a paraneoplastic rheumatic syndrome in the elderly (bicytopenia and PMR preceding acute myeloid leukemia).
Anton E
J Clin Rheumatol; 2007 Apr; 13(2):114. PubMed ID: 17414547
[No Abstract] [Full Text] [Related]
19. Association of Anti-Transcription Intermediary Factor 1γ Antibodies With Paraneoplastic Rheumatic Syndromes Other Than Dermatomyositis.
Venalis P; Selickaja S; Lundberg K; Rugiene R; Lundberg IE
Arthritis Care Res (Hoboken); 2018 Apr; 70(4):648-651. PubMed ID: 28704599
[TBL] [Abstract][Full Text] [Related]
20. Rheumatology and oncology: an updated review of rheumatic manifestations of malignancy and anti-neoplastictherapy.
Alias A; Rodriguez EJ; Bateman HE; Sterrett AG; Valeriano-Marcet J
Bull NYU Hosp Jt Dis; 2012; 70(2):109-14. PubMed ID: 22892000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
